Graves Disease
Information
- Disease name
- Graves Disease
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00150137 | Completed | Phase 4 | Antithyroid Drugs During Radioiodine Therapy | January 2003 | December 2004 |
| NCT00400465 | Completed | Phase 4 | Is the Routine Pressure Dressing After Thyroidectomy Necessary? | December 2006 | September 2007 |
| NCT00432146 | Completed | Effect of Lugol's Solution in the Patients With Graves' Disease | September 2005 | September 2006 | |
| NCT00677469 | Completed | N/A | Low Doses of Cholestyramine in the Treatment of Hyperthyroidism | July 2007 | January 2008 |
| NCT00782366 | Completed | Predictive Genetic Risk Assessment Trial | March 2008 | January 2010 | |
| NCT00796913 | Completed | N/A | Remission Induction and Sustenance in Graves' Disease 2 | January 7, 2008 | May 15, 2015 |
| NCT00946296 | Completed | Phase 4 | Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease | April 2005 | April 2013 |
| NCT01039818 | Completed | Phase 3 | Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism | February 1997 | August 2011 |
| NCT01227499 | Completed | Differential Diagnosis of STA-PSV in Thyrotoxicosis | June 2010 | November 2011 | |
| NCT01560299 | Completed | N/A | Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's Patients | February 2010 | January 2012 |
| NCT01727973 | Completed | Phase 1/Phase 2 | Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy | October 2012 | November 2013 |
| NCT02190214 | Completed | Thyroid Disorders in Malaysia: A Nationwide Multicentre Study | August 2014 | September 2016 | |
| NCT02376088 | Completed | Characteristics of Islet β-cell Functions in Chinese Patients With Graves' Disease | June 2011 | June 2014 | |
| NCT02491567 | Completed | DNA Methylation and Autoimmune Thyroid Diseases | September 2014 | April 2018 | |
| NCT02798965 | Completed | N/A | Prevalence of Circulating Parvovirus Genome in Recently Diagnosed Graves' Disease: a Case-control Study | December 2010 | May 2014 |
| NCT02973802 | Completed | Phase 1 | ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy | September 2016 | February 14, 2018 |
| NCT02993302 | Completed | Phase 2 | Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients | July 2014 | March 2015 |
| NCT03009357 | Completed | Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis | November 2016 | August 2017 | |
| NCT03013257 | Completed | N/A | HIFU vs RAI in the Relapsed Graves' Disease | April 25, 2017 | June 30, 2020 |
| NCT03498417 | Completed | Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy | June 20, 2018 | July 20, 2018 | |
| NCT03590080 | Completed | Impact of Intravenous Methylprednisolone Treatment on Blood Pressure | January 1, 2011 | December 30, 2015 | |
| NCT03667157 | Completed | Phase 4 | Liver Function After Intravenous Methylprednisolone Administration | January 1, 2012 | October 30, 2016 |
| NCT03941184 | Completed | Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity | January 1, 1995 | November 10, 2020 | |
| NCT03969108 | Completed | Phase 4 | Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment | August 6, 2019 | November 13, 2019 |
| NCT04080505 | Completed | Phase 3 | Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy? | February 10, 2015 | March 3, 2023 |
| NCT04239521 | Completed | The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata | October 1, 2020 | November 28, 2022 | |
| NCT04391439 | Completed | Heart Rhythm After Intravenous Methylprednisolone Administration | January 1, 2011 | February 20, 2020 | |
| NCT04682340 | Completed | Analysis of BPA Concentration in Serum in Women of Reproductive Age With Autoimmune Thyroid Disease | December 22, 2020 | January 19, 2022 | |
| NCT04686006 | Completed | Effective Iodide Therapy for Untreated Patients With Graves' Hyperthyroidism Avoiding Thionamide Drugs With Many Side Effects | April 1, 1996 | ||
| NCT04932135 | Completed | Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of Hyperthyroidism | June 8, 2021 | October 30, 2023 | |
| NCT05118542 | Completed | Phase 3 | Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis | January 1, 2019 | August 1, 2020 |
| NCT05713097 | Completed | TSI and Its Relationship With Graves' Disease Relapse | January 2, 2022 | August 31, 2022 | |
| NCT05945784 | Completed | Exploring Accessible Beauty for Individuals With Upper Extremity Deficits | July 21, 2023 | September 29, 2023 | |
| NCT06451016 | Completed | N/A | Effects of Vitamin D Supplementation on Muscle Function Among Grave's Disease Patients | January 1, 2021 | January 15, 2024 |
| NCT06426758 | Not yet recruiting | Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation | May 30, 2024 | September 1, 2027 | |
| NCT06327828 | Not yet recruiting | N/A | Methimazole in Graves' Disease - Comparing the Computer-aided Treatment DigiThy Versus Usual Care | September 1, 2024 | October 1, 2026 |
| NCT06204393 | Recruiting | To Investigate the Effect of 2019 Novel Coronavirus Infection on the Condition of Patients With Hyperthyroidism | January 7, 2023 | August 7, 2024 | |
| NCT06240455 | Recruiting | Phase 2 | Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz | January 11, 2024 | August 31, 2026 |
| NCT06081439 | Recruiting | Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease | September 12, 2019 | December 20, 2025 | |
| NCT06134219 | Recruiting | N/A | Course for Brain Fatigue After Graves' Disease Controlled Study | October 10, 2023 | October 10, 2026 |
| NCT05461820 | Recruiting | Phase 4 | Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease | May 1, 2018 | July 31, 2030 |
| NCT05510609 | Recruiting | N/A | Three-dimensional Ultrasonography Thyroid Volume Measurement. | May 9, 2022 | November 1, 2022 |
| NCT05635266 | Recruiting | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | October 26, 2021 | October 2025 | |
| NCT05678374 | Recruiting | Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease | October 1, 2019 | December 20, 2024 | |
| NCT03517579 | Recruiting | N/A | Personalized Treatment in Thyroid Disorders | December 11, 2018 | December 15, 2024 |
| NCT05774535 | Recruiting | Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery | September 5, 2022 | September 2024 | |
| NCT05907668 | Recruiting | Phase 2 | A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease | May 15, 2023 | May 2025 |
| NCT05964452 | Recruiting | Efficacy of Methimazole Dosing Algorithm | February 14, 2022 | February 14, 2024 | |
| NCT06275373 | Recruiting | The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction | May 12, 2021 | December 12, 2027 | |
| NCT06309316 | Recruiting | N/A | The Impact of Person Centred Care (PCC) in Grave's Disease | March 25, 2024 | December 30, 2028 |
| NCT05435547 | Recruiting | Phase 4 | Preoperative Corticosteroids in Autoimmune Thyroid Disease | June 16, 2023 | December 31, 2025 |
| NCT01320813 | Terminated | N/A | Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy | September 2011 | September 2013 |
| NCT04789993 | Unknown status | Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up | March 15, 2021 | April 30, 2021 | |
| NCT03066076 | Unknown status | Phase 3 | Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy | March 1, 2017 | June 1, 2019 |
| NCT03303053 | Unknown status | Phase 3 | Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism | May 11, 2017 | March 1, 2018 |
| NCT02210741 | Unknown status | Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease | August 2014 | February 2024 | |
| NCT01616108 | Unknown status | Phase 2/Phase 3 | Bupivacaine Injection of Eye Muscles to Treat Strabismus | April 2012 | September 2020 |
| NCT02203682 | Unknown status | Phase 2 | Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy | July 2014 | July 2022 |
| NCT04135573 | Unknown status | The Relationship Between NK Cell and Graves' Disease | October 15, 2018 | June 30, 2022 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100647
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006111